Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma - Concepedia

Concepedia

Publication | Closed Access

Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma

14

Citations

10

References

2007

Year

Craig C. Hofmeister, Buffy Jansak, Nathan Denlinger, Eric H. Kraut, D.M. Benson, Sherif S. Farag

Leukemia Research

Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPathologyLiposomal DoxorubicinMultiple MyelomaArsenic TrioxideOncologyRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1